Patent Assignment
Reel/Frame 055145/0553
Assignment of Assignor's Interest
Recorded: 2021-02-04
Pages: 4
Assignee
HELSINN THERAPEUTICS (US) INC
170 S WOOD AVENUE, ISELIN, NEW JERSEY, 08830
Covered Property
(1)
New Centrally-Active Ghrelin Agonist and Medical Uses Thereof
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 4, 2021
From: MARTINEZ-LOI, MARIELLE
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 055145/0529 →
Assignment of Assignor's Interest
Feb 4, 2021
From: HELSINN THERAPEUTICS (US) INC; HELSINN ADVANCED SYNTHESIS SA
To: HELSINN HEALTHCARE SA
Reel/Frame 055145/0557 →
Assignment of Assignor's Interest
Feb 4, 2021
From: GIULIANO, CLAUDIO; PIETRA, CLAUDIO
To: HELSINN HEALTHCARE SA
Reel/Frame 055220/0845 →
Security Interest
Dec 30, 2022
From: HELSINN HEALTHCARE SA; HELSINN THERAPEUTICS (U.S.), INC.; HELSINN BIREX PHARMACEUTICALS LIMITED
To: HAMILTON SA LLC
Reel/Frame 062254/0888 →
Release of Security Interest
Sep 20, 2023
From: HAMILTON SA LLC
To: HELSINN HEALTHCARE SA; HELSINN THERAPEUTICS (U.S.), INC.; HELSINN BIREX PHARMACEUTICALS LIMITED
Reel/Frame 064961/0567 →